Dr. Kanner does not believe that Alfred de Musset fell in love at 4, Byron at 8, Dante at 9, Goethe at 10. He believes that they, like many another very young child, had a “crush” on someone.

Dr. Kanner serves as Chief Scientific Officer at Caribou Biosciences where he is leading preclinical discovery, technical operations, and translational development of genome-edited cell therapies.

Dr. Kanner brings more than 25 years of experience in drug discovery and development and will lead Caribou’s research and development of new applications for its gene editing technology.

Dr. Kanner: In my clinical experience, I’ve found that people with epilepsy do better when we effectively manage comorbid depression or anxiety. We have done some studies to test these observations.

Dr. Asperger described adults on the spectrum, where he made the point that we can be very successful especially in technical work. Dr. Kanner’s work was limited to children and teens, but he ...

Dr. Kanner serves as Chief Scientific Officer at Caribou Biosciences where he is leading preclinical discovery, technical operations, and translational development of genome-edited cell therapies.